Weekly Reports | Oct 02 2020
Our top ten news from 24 September 2020 to 01 October 2020 (ranked according to popularity).
Friday 25 September 2020 – 12:40 PM
SPONSORED: 2020 has been a stand-out year for Vonex, as it positions itself as the telco of choice for small to medium-sized enterprises (SMEs)
Friday 25 September 2020 – 10:09 AM
Tesla has ushered in a new era for electric vehicle battery technology that could shake up the materials supply chain.
Thursday 24 September 2020 – 10:00 AM
Dear time-conscious investor: US election remains too uncertain to call; a new strategy for dividend-seekers; plus one under-reported record from the August results seasonIn this week’s Weekly Insights:-All Eyes On November 3-Income Seekers Need A New Strate
Thursday 24 September 2020 – 10:33 AM
A glance through the latest expert views and predictions about commodities. Tin; thermal coal; battery materials; gold; and iron ore.
Tuesday 29 September 2020 – 11:17 AM
Sales of a2 Milk's infant formula within China remain robust but the slump in daigou sales has caught the market napping and forecasts for FY21 are downgraded sharply.
Thursday 24 September 2020 – 12:24 PM
Ahead of the Herd's Rick Mills suggests a slow recovery from the virus is not going to dampen demand for gold, silver and copper.
Thursday 01 October 2020 – 10:58 AM
Covid is being touted by many as the perfect opportunity to accelerate the transition to a circular, sustainable economy. It has exposed the vulnerable underbellies of critical and not-so-critical industries; guided to a grand future for others; and triggered fundamental shifts in economic monetary policy, the repercussions of which will reverberate for decades
Friday 25 September 2020 – 10:32 AM
Weekly Broker Wrap: NBN's $700m investment may not necessarily lead to lower wholesale enterprise broadband prices; UBS prefers under-appreciated logistics landowners
Wednesday 30 September 2020 – 10:30 AM
Extra Edition of the Broker Call Report
Monday 28 September 2020 – 11:00 AM
The New Criterion's Tim Boreham ascertains the impact a proposed regulatory change to medical cannabis will have on the market.